Skip to main content
SpringerLink
Log in

Genetic Factors in Lung Cancer

  • Chapter
Familial and Hereditary Tumors

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 136))

  • 67 Accesses

Abstract

Lung cancer is the commonest malignancy in the male sex and a major public health problem in the world. These tumors provide the most appropriate example of what is usually associated with the concept of neoplasia: pain, suffering, distress, and rapid death. This dismal outlook should not obscure the progress achieved in the basic knowledge of lung tumor biology and the consequent hope of a gradual improvement in prevention and clinical management.

The sharp and continuing rise in death from lung cancer, nearly all from cigarette smoking, is now widely recognized as a medical, social and political scandal. J. C. Bailar E. M. Smith (1986)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davesa SS, Silverman DT, Young JL et al. (1987) Cancer incidence and mortality trends among white in the USA, 1947-1984. JNCI 79:701–770

    Google Scholar 

  2. Levi F, Te VC, La Vecchia C (1990) Changes in cancer incidence in the Swiss canton of Vaud 1978–87. Ann Oncol 1:293–297

    PubMed  CAS  Google Scholar 

  3. Zanetti R, Crosignani P (1992) Cancer in Italy: incidence data from cancer registries 1983-87. Lega Italiana per la Lotta contro i Tumori, Torino

    Google Scholar 

  4. Silverberg M, Lubera JL (1989) Cancer statistics, 1989. CA 39:3–21

    Article  PubMed  CAS  Google Scholar 

  5. Horm JW, Kessler LG (1986) Falling rates of lung cancer in men in USA. Lancet 1:425–426

    Article  PubMed  CAS  Google Scholar 

  6. Bleehen NM (1989) Lung cancer — still a long road ahead. Br J Cancer 61: 493–494

    Article  Google Scholar 

  7. Doll R, Hill AB (1964) Mortality in relation to smoking: ten years’ observation on British doctors. Br Med J 1:1399–1410, 1460-1467

    Article  PubMed  CAS  Google Scholar 

  8. Doll R, Peto R (1986) Mortality in relation to smoking: 20 year’s observation on male British doctors. Br Med J 11:1525–1531

    Google Scholar 

  9. Boyle P (1993) The hazard of passive — and active — smoking. N Engl J Med 328:1708–1709

    Article  PubMed  CAS  Google Scholar 

  10. Halpern MT, Gillespie BW, Warner KE (1993) Pattern of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 85:457–464

    Article  PubMed  CAS  Google Scholar 

  11. Dalager NA, Pickle LW, Mason TJ et al. (1986) The relation of passive smoking to lung cancer. Cancer Res 46:4808–4811

    PubMed  CAS  Google Scholar 

  12. Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risk of cancer in the USA today. JNCI 66:1191–1308.

    PubMed  CAS  Google Scholar 

  13. Lerchen ML, Wiggins CL, Samet JM (1987) Lung cancer and occupation in New Mexico. JNCI 79:639–645

    PubMed  CAS  Google Scholar 

  14. Tomasek L, Darby S, Swerdlow AJ et al. (1993) Radon exposure and cancers other than lung cancer among uranium miners in West Bohemia. Lancet 341: 919–923

    Article  PubMed  CAS  Google Scholar 

  15. Blot WJ, Fraumeni JF (1976) Geographic patterns of lung cancers: industrial correlations. Am J Epidemiol 103:539–547

    PubMed  CAS  Google Scholar 

  16. Carroll KK, Khor HT (1975) Dietary fat in relation to tumorigenesis. Prog Biochem Pharmacol 10:308–353

    PubMed  CAS  Google Scholar 

  17. Hinds MW, Kolonel LN, Lee J et al. (1983) Dietary cholesterol and lung cancer risk among men in Hawaii. Am J Clin Nutr 37:192–193

    PubMed  CAS  Google Scholar 

  18. Wynder EL, Hebert JR, Kabat GC (1987) Association of dietary fat and lung cancer. JNCI 79:631–637

    PubMed  CAS  Google Scholar 

  19. Tannenbaum A (1942) The genesis and growth of tumors. III. Effect of a high fat diet. Cancer Res 2:468–475

    CAS  Google Scholar 

  20. Beems RB, van Beek L (1984) Modifying effect of dietary fat on benzopyrene-induced respiratory tract tumors in hamsters. Carcinogenesis 5:413–417

    Article  PubMed  CAS  Google Scholar 

  21. Stahelin HB, Buess E, Brubacher G (1984) Cancer, vitamins and plasma lipids: prospective Basel study. JNCI 73:1463–1468

    PubMed  CAS  Google Scholar 

  22. Menkes MS, Comstock GW, Vuilleumier JP et al. (1986) Serum beta-carotene, vitamins A and E, Selenium, and the risk of lung cancer. N Engl J Med 315:1250–1254

    Article  PubMed  CAS  Google Scholar 

  23. Baylin S, Mendelsohn G (1980) Ectopic hormone production by tumors. Endocr Rev 1:45–77

    Article  PubMed  CAS  Google Scholar 

  24. Korman LY, Carney DN, Citron ML et al. (1986) Secretin/VIP stimulated secretion of bombesin/gastrin releasing peptide from human small cell carcinoma of the lung. Cancer Res 46:1214–1218

    PubMed  CAS  Google Scholar 

  25. Spiessl B, Beahrs OH, Hermanek P et al. (1990) TNM atlas. Springer, Berlin Heidelberg New York, pp 134–144

    Google Scholar 

  26. Dodds L, Davis S, Polissar L (1986) A population-based study of lung cancer incidence trends by histologic types, 1974-81. JNCI 76:21–29

    PubMed  CAS  Google Scholar 

  27. Naruke T, Goya T, Tsuchiya R et al. (1989) Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 97:350

    Google Scholar 

  28. Idhe DC (1992) Chemotherapy of lung cancer. N Engl J Med 327:1434–1441

    Article  Google Scholar 

  29. Volm M, Hahn EW, Mattern J et al. (1988) Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res 48:2923–2928

    PubMed  CAS  Google Scholar 

  30. Sahin AA, Ro JY, El-Naggar AK et al. (1990) Flow cytometric analysis of the DNA content of non-small cell lung cancer. Cancer 65:530–537

    Article  PubMed  CAS  Google Scholar 

  31. Miyamoto H, Harada M, Isobe H et al. (1991) Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer. Cancer Res 51:6346–6350

    PubMed  CAS  Google Scholar 

  32. Alama A, Costantini M, Repetto L et al. (1990) Thymidine labelling index as prognostic factor in resected non-small cell lung cancer. Eur J Cancer 26: 622–625

    Article  PubMed  CAS  Google Scholar 

  33. Macchiarini P, Fontanini G, Hardin MH et al. (1992) Relation of neovascular-ization to metastasis of non-small-cell lung cancer. Lancet 340:145–146

    Article  PubMed  CAS  Google Scholar 

  34. Miyake M, Taki T, Hitomi S et al. (1992) Correlation of expression of H/Le/Leantigens with survival in patients with carcinoma of the lung. N Engl J Med 327:14–18

    Article  PubMed  CAS  Google Scholar 

  35. Hakamori S (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52:257–331

    Article  Google Scholar 

  36. Ihde DC, Minna JD (1991) Non-small cell lung cancer II treatment. Curr Probl Cancer 15:105–154

    PubMed  CAS  Google Scholar 

  37. Lowenbraun S, Birch R, Buchanan R et al. (1984) Combination chemotherapy in small cell lung carcinoma: a randomized study of two intensive regimens. Cancer 54:2344–2350

    Article  PubMed  CAS  Google Scholar 

  38. Jackson DV Jr, Case LD, Zekan PJ et al. (1988) Improvement of long-term survival in extensive small-cell lung cancer. J Clin Oncol 6:1161–1169

    PubMed  Google Scholar 

  39. Fukuoka M, Furuse K, Saijo N et al. (1991) Randomized trial of cyclophos-phamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. JNCI 83:855–861

    PubMed  CAS  Google Scholar 

  40. Lynch HT, Lynch JF (1989) Genetic epidemiology of lung cancer. In: Lynch HT, Hirayama T (eds) Genetic epidemiology of cancer. CRC Press, Boca Raton, pp 279–288

    Google Scholar 

  41. Brismam R, Baker RR, Elkins R et al. (1967) Carcinoma of lung in 4 siblings. Cancer 20:2048–2053

    Article  Google Scholar 

  42. Joishi SK, Cooper RA, Bowley PT (1977) Alveolar cell carcinoma in identical twins. Ann Intern Med 87:447–450

    Google Scholar 

  43. Goffman TE, Hassinger DD, Mulvihill JJ (1982) Familial respiratory tract cancer. JAMA 247:1020–1023

    Article  PubMed  CAS  Google Scholar 

  44. Tokuhata GK, Lilienfeld AM (1963) Familial aggregation of lung cancer in humans. JNCI 30:289–312

    PubMed  CAS  Google Scholar 

  45. Ooi WL, Elston RC, Chen VW et al. (1986) Increased familial risk for lung cancer. JNCI 76:217–222

    PubMed  CAS  Google Scholar 

  46. Sellers TE, Ooi WL, Elston RC et al. (1987) Increased familial risk for non-lung cancer among relatives of lung cancer patients. Am J Epidemiol 126:237–246

    Article  PubMed  CAS  Google Scholar 

  47. McDuffie HH (1991) Clustering of cancer in families of patients with primary lung cancer. J Clin Epidemiol 44:69–76

    Article  PubMed  CAS  Google Scholar 

  48. Lynch HT, Kimberling WJ, Markvicka SE et al. (1986) Genetics and smoking-associated cancers. Cancer 57:1640–1646

    Article  PubMed  CAS  Google Scholar 

  49. Sellers TA, Bailey-Wilson JE, Elston RC et al. (1990) Evidence for mendelian inheritance in the pathogenesis of lung cancer. JNCI 82:1272–1279

    PubMed  CAS  Google Scholar 

  50. Elston RC, George VT (1989) Age of onset, age of examination, and other covariates in the analysis of family data. Genet Epidemiol 6:217–220

    Article  PubMed  CAS  Google Scholar 

  51. Sellers TA, Elston RC, Atwood LD et al. (1992) Lung cancer histologic type and family history of cancer. Cancer 69:86–91

    Article  PubMed  CAS  Google Scholar 

  52. Ambrosone CB, Rao J, Michalex AM et al. (1993) Lung cancer histologic types and family history of cancer. Cancer 72:1192–1198

    Article  PubMed  CAS  Google Scholar 

  53. Law MR (1990) Genetic predisposition to lung cancer. Br J Cancer 61:195–206

    Article  PubMed  CAS  Google Scholar 

  54. Nazart-Stewart V, Motulsky AG, Eaton DL et al. (1993) The glutathione S-transferase polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53:2313–2318

    Google Scholar 

  55. Oesch F, Schmassmann H, Ohnhaus E et al. (1980) Mono-oxygenase, epoxide hydrolase, and glutathione-S transferase activities in human lung. Carcinogenesis 1:827–832

    Article  PubMed  CAS  Google Scholar 

  56. Harris CC, Autrup H, Connor R et al. (1976) Interindividual variation in binding of benzopyrene to DNA. Science 194:1067–1069

    Article  PubMed  CAS  Google Scholar 

  57. Kouri RE, McKinney CE, Slomiany DR et al. (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analysed in cryopreserved lymphocytes. Cancer Res 42:5030–5035

    PubMed  CAS  Google Scholar 

  58. Ambre J, Graeff D, Bures F et al. (1977) Antipyrine metabolism and bronchogenic carcinoma. J Med 8:57–64

    PubMed  CAS  Google Scholar 

  59. Danhof M (1980) Antipyrine metabolite profile as a tool in the assessment of the activity of different drug oxidising enzymes in man. Doctoral thesis, University of Leiden, The Netherlands

    Google Scholar 

  60. Idle JR, Mahgoub A, Angelo MM et al. (1979) The metabolism of debrisoquine in man. Br J Clin Pharmacol 7:257–263

    PubMed  CAS  Google Scholar 

  61. Eichelbaum M, Baur MP, Dengler HJ et al. (1987) Chromosomal assignment of human P-450 (debrisoquine/spartein type) to chromosome 22. Br J Clin Pharmacol 23:455–459

    PubMed  CAS  Google Scholar 

  62. Steiner E, Iselius L, Alvan G et al. (1985) A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquine. Clin Pharmacol Ther 38:394–399

    Article  PubMed  CAS  Google Scholar 

  63. Ayesh R, Idle JR, Ritchie JC et al. (1984) Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312:169–171

    Article  PubMed  CAS  Google Scholar 

  64. Caporaso N, Hoover R, Aisner S et al. (1988) Debrisoquine metabolic phenotype and the risk of lung cancer. Proc Am Soc Clin Oncol 8:336–338

    Google Scholar 

  65. Roots I, Drakoulis N, Ploch M et al. (1988) Debrisoquine hydroxylation phenotype, acetylation phenotype and ABO blood groups as genetic host factors of lung cancer risk. Klin Wochenschr 66[Suppl XI]:87–92

    Article  PubMed  Google Scholar 

  66. Richardson GE, Johnson BE (1993) The biology of lung cancer. Semin Oncol 20:105–127

    PubMed  CAS  Google Scholar 

  67. Reynolds SH, Anna CK, Brown KC et al. (1991) Activated protooncogenes in human lung tumors from smokers. Proc Natl Acad Sci USA 88:1085–1089

    Article  PubMed  CAS  Google Scholar 

  68. Motoijma K, Urano T, Nagata Y et al. (1991) Mutations in the K-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. Am J Gastroenterol 86:1784–1788

    Google Scholar 

  69. Pursiaines KH, Hackman P, Ridanpaa M et al. (1993) K-ras mutations in human adenocarcinoma of the lung. Int J Cancer 53:250–256

    Article  Google Scholar 

  70. Saksela K, Makela TP, Alitao K (1989) Oncogene expression in small-cell lung cancer cell lines and a testicular germ-cell tumor. Int J Cancer 44:182–185

    Article  PubMed  CAS  Google Scholar 

  71. Veale D, Kerr N, Gibson GJ et al. (1989) Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res 49: 1313–1317

    PubMed  CAS  Google Scholar 

  72. Pezzella F, Turley H, Kuzu I et al. (1993) bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690–694

    Article  PubMed  CAS  Google Scholar 

  73. Whang-Peng J, Kao-Shan CS, Lee CS et al. (1982) Specific chromosome defect associated with human small-cell lung cancer. Science 215:181–182

    Article  PubMed  CAS  Google Scholar 

  74. Morstyn G, Brown J, Novak U et al. (1987) Heterogeneous cytogenetic abnormalities in small cell lung cancer cell lines. Cancer Res 47:3322–3327

    PubMed  CAS  Google Scholar 

  75. Yokota J, Wada M, Shimosato Y et al. (1987) Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 84:9252–9256

    Article  PubMed  CAS  Google Scholar 

  76. Mori N, Yokota J, Oshimura M et al. (1989) Concordant deletions of chromo-some 3p and loss of heterozygosity for chromosome 13 and 17 in small cell lung carcinoma. Cancer Res 49:5130–5135

    PubMed  CAS  Google Scholar 

  77. Horio Y, Takahashi T, Kuroishi T et al. (1993) Prognostic significance of p53 mutations and 3p deletion in primary resected non-small cell lung cancer. Cancer Res 53:1–4

    PubMed  CAS  Google Scholar 

  78. Iggo R, Gatter K, Bartek J et al. (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675–679

    Article  PubMed  CAS  Google Scholar 

  79. Chiba I, Takahashi T, Nau MM et al. (1990) Mutations of p53 are frequent in primary, resected non-small cell lung cancer. Oncogene 5:1603–1610

    PubMed  CAS  Google Scholar 

  80. Marchetti A, Buttitta F, Merlo G et al. (1993) p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Cancer Res 53:2846–2851

    PubMed  CAS  Google Scholar 

  81. Morkve O, Halvorsen OJ, Skjaevern R et al. (1993) Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas. Anticancer Res 13:571–578

    PubMed  CAS  Google Scholar 

  82. Suzuki H, Takahashi T, Kuroishi T et al. (1992) p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 52:734–736

    PubMed  CAS  Google Scholar 

  83. Sozzi G, Miozzo M, Donghi R et al. (1992) Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52:6079–6082

    PubMed  CAS  Google Scholar 

  84. Sundaresan V, Ganly P, Hasleton P et al. (1992) p53 and chromosome 3 abnormalities, characteristics of malignant lung tumors, are detectable in pre-invasive lesions of the bronchus. Oncogene 7:1989–1997

    PubMed  CAS  Google Scholar 

  85. Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319:525–532

    Article  PubMed  CAS  Google Scholar 

  86. Mazars R, Pujol P, Maudelonde T et al. (1991) p53 mutations in ovarian cancer: a late event? Oncogene 6:1685–1690

    PubMed  CAS  Google Scholar 

  87. Sameshima Y, Matsuno Y, Hirohashi S et al. (1992) Alterations of the p53 gene are common and critical events for the maintenance of the malignant phenotypes in small-cell lung carcinoma. Oncogene 7:451–457

    PubMed  CAS  Google Scholar 

  88. Takahashi T, Carbone D, Takahashi To et al. (1992) Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res 52:2340–2343

    PubMed  CAS  Google Scholar 

  89. Laviguer A, Maltby V, Mock D et al. (1989) High incidence of lung, bone and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 9:3982–3991

    Google Scholar 

  90. Harbour JW, Lai SL, Wang-Peng J et al. (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353–357

    Article  PubMed  CAS  Google Scholar 

  91. Hensel CH, Hsieh CL, Gazdar Af et al. (1990) Altered structure and expression f the human Rb susceptibility gene in small cell lung cancer. Cancer Res 50:3067–3072

    PubMed  CAS  Google Scholar 

  92. Murakami Y, Katahira M, Makino R et al. (1991) Inactivation of the retinoblastoma ene in a human lung carcinoma cell line. Oncogene 6:37–42

    PubMed  CAS  Google Scholar 

  93. Reissmann PY, Koga H, Takahashi R et al. (1993) Inactivation of the Rb susceptibility gene in non-small cell lung cancer. Oncogene 8:1913–1919

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Patologia Medica Policlinico, Università degli Studi di Modena, Via del Pozzo, 71, 41100, Modena, Italy

    Prof. Dr. M. Ponz de Leon

Authors
  1. Prof. Dr. M. Ponz de Leon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

de Leon, M.P. (1994). Genetic Factors in Lung Cancer. In: Familial and Hereditary Tumors. Recent Results in Cancer Research, vol 136. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85076-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85076-9_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85078-3

  • Online ISBN: 978-3-642-85076-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation